Drug-induced movement disorders in children and adolescents.
The use of psychotropic medication among children and adolescents is increasing with a concomitant increase in the incidence of drug-related movement disorders. This class of adverse reactions to medications can be divided into those that are acute in onset, others that are continuous as long as the offending drug is administered, and a final category consisting of symptoms that are persistent, even after the causative agent has been discontinued. Within these three categories, this review discusses the epidemiology, risk factors, clinical features and treatment of acute dystonic reactions, drug-induced parkinsonism, neuroleptic malignant syndrome, serotonin syndrome, acute akathisia, and the tardive syndromes. In addition, drugs that commonly cause tremor, chorea, or myoclonus are included.
Rodnitzky
Robert L
RL
University of Iowa, Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA. robert-rodnitzky@uiowa.edu.
D000208:Acute Disease; D000293:Adolescent; D000367:Age Factors; D002648:Child; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D006801:Humans; D015994:Incidence; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000627:therapeutic use*; D012307:Risk Factors
D011619:Psychotropic Drugs